Hancock Jaffe Laboratories Inc ROIC
Mi az Hancock Jaffe Laboratories Inc ROIC?
A ROIC az Hancock Jaffe Laboratories Inc - -130.76%
Mi a ROIC meghatározása?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC a Health Care szektor a NASDAQ-on cégekben a Hancock Jaffe Laboratories Inc -hoz képest
Mit csinál Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
roic -hoz hasonló cégek Hancock Jaffe Laboratories Inc
- Alternate Health nak ROIC -131.22% van
- Akari Therapeutics Plc nak ROIC -131.14% van
- Ideanomics Inc nak ROIC -130.90% van
- Claren nak ROIC -130.90% van
- KWESST Micro Systems nak ROIC -130.86% van
- KWESST Micro Systems nak ROIC -130.86% van
- Hancock Jaffe Laboratories Inc nak ROIC -130.76% van
- Tetra Bio-Pharma nak ROIC -130.74% van
- Odyssey Semiconductor Technologies nak ROIC -130.61% van
- G2 Technologies nak ROIC -130.35% van
- T2 Biosystems Inc nak ROIC -129.43% van
- Allena Pharmaceuticals Inc nak ROIC -129.33% van
- Aurum Resources Ltd nak ROIC -128.63% van